scholarly journals Respiratory chain supercomplexes associate with the cysteine desulfurase complex of the iron–sulfur cluster assembly machinery

2018 ◽  
Vol 29 (7) ◽  
pp. 776-785 ◽  
Author(s):  
Lena Böttinger ◽  
Christoph U. Mårtensson ◽  
Jiyao Song ◽  
Nicole Zufall ◽  
Nils Wiedemann ◽  
...  

Mitochondria are the powerhouses of eukaryotic cells. The activity of the respiratory chain complexes generates a proton gradient across the inner membrane, which is used by the F1FO-ATP synthase to produce ATP for cellular metabolism. In baker’s yeast, Saccharomyces cerevisiae, the cytochrome bc1 complex (complex III) and cytochrome c oxidase (complex IV) associate in respiratory chain supercomplexes. Iron–sulfur clusters (ISC) form reactive centers of respiratory chain complexes. The assembly of ISC occurs in the mitochondrial matrix and is essential for cell viability. The cysteine desulfurase Nfs1 provides sulfur for ISC assembly and forms with partner proteins the ISC-biogenesis desulfurase complex (ISD complex). Here, we report an unexpected interaction of the active ISD complex with the cytochrome bc1 complex and cytochrome c oxidase. The individual deletion of complex III or complex IV blocks the association of the ISD complex with respiratory chain components. We conclude that the ISD complex binds selectively to respiratory chain supercomplexes. We propose that this molecular link contributes to coordination of iron–sulfur cluster formation with respiratory activity.

2013 ◽  
Vol 22 (22) ◽  
pp. 4460-4473 ◽  
Author(s):  
Sze Chern Lim ◽  
Martin Friemel ◽  
Justine E. Marum ◽  
Elena J. Tucker ◽  
Damien L. Bruno ◽  
...  

Medicina ◽  
2010 ◽  
Vol 46 (10) ◽  
pp. 679
Author(s):  
Vida Gendvilienė ◽  
Irma Martišienė ◽  
Danguolė Zablockaitė ◽  
Jonas Jurevičius

The aim of the study was to investigate the effect of inhibitors of mitochondrial respiratory chain complexes I, III, and IV on the electromechanical activity in human myocardium. Material and methods. The experiments were performed on the human myocardial strips obtained from patients with heart failure (NYHA class III or IV) using a conventional method of registration of myocardial electromechanical activity. Under the perfusion with physiological Tyrode solution (control), contraction force (P) was 0.94±0.12 mN (n=16), relaxation time (t50) was 173.38±5.03 ms (n=15), action potential durations measured at 50% (AP50) and 90% (AP90) repolarization were 248.96±13.38 ms and 398.59±17.93 ms, respectively (n=13). Results. The inhibition of respiratory chain complex I by rotenone (3×10–5 M, the highest concentration applied) decreased contraction force of human myocardium to 48.99%±14.74% (n=3) (P<0.05); AP50, to 81.34%±15.81%; and AP90, to 87.28%±7.25% (n=3) (P>0.05) of control level, while relaxation time and resting tension remained almost unchanged. Antimycin A, an inhibitor of complex III, applied at the highest concentration (3×10–4 M) reduced P to 41.66%±8.8% (n=5) (P<0.001) and marginally increased t50 and decreased the durations of AP. Anoxia (3 mM Na2S2O4) that inhibits the activity of complex IV reduced the contraction force to 9.23%±3.56% (n=6) (P<0.001), AP50 and AP90 to 65.46%±9.95% and 71.07%±8.39% (n=5) (P<0.05) of control level, respectively; furthermore, the resting tension augmented (contracture developed). Conclusions. Our results show that the inhibition of respiratory chain complex IV had the strongest inhibitory effect on the electromechanical activity of failing human myocardium.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 3585-3585
Author(s):  
Shrivani Sriskanthadevan ◽  
Skrtic Marko ◽  
Bozhena Livak ◽  
Yulia Jitkova ◽  
Rose Hurren ◽  
...  

Abstract Abstract 3585 Recent studies suggest that dysregulated mitochondrial oxygen consumption promotes the growth of AML cells. Therefore, we characterized the structure and metabolic function of the mitochondria in AML and normal G-CSF-mobilized hematopoietic mononuclear cells (PBSCs). Compared to PBSCs, 1o AML cells had increased mitochondrial mass as demonstrated by an increased mitochondrial DNA copy number and increased activity of matrix enzyme citrate synthase. The increased mitochondrial mass observed in 1o AML cells may represent larger mitochondria and/or more numerous mitochondria. Therefore, we evaluated the mitochondria of 1o AML and normal CD34+ hematopoietic cells by electron microscopy. The mitochondria in 1o AML cells were larger in area, but fewer in number compared to normal CD34+ cells. Mitochondria contain the respiratory chain complexes that promote oxidative phosphorylation. Given the dysregulated mitochondrial biogenesis in 1o AML cells, we examined the levels and capacity of the respiratory complexes in 1o AML and normal PBSCs. When normalized for mitochondrial mass, 1o AML cells (n = 12) had reduced activity of respiratory complexes III and IV compared to PBSCs (n = 10) (Mean complex III activity AML vs PBSC: 0.32 ± 0.04 RU vs 0.66 ± 0.11 RU p = 0.0063; Mean complex IV activity AML vs PBSC: 0.13 ± 0.01 RU vs 0.24 ± 0.02 RU, p= 0.0003). We evaluated the capacity of the respiratory complexes in AML cells and PBSCs by treating with increasing concentrations of the complex III inhibitor antimycin, and measuring the changes in oxygen consumption. AML cells displayed heightened sensitivity to the complex III inhibitor and less reserve capacity in the respiratory complex compared to PBSCs (mean concentration of antimycin required to reduce oxygen consumption by 50%: AML (n = 11) vs PBSC (n = 3): 13.7 ± 1.6 nM vs 29.0 ± 2.4 nM; p = 0.0007). AML cell lines were similar to 1o AML cells with decreased basal respiratory complex activity and reserve capacity compared to PBSCs. Given the reduced levels and reserve in the respiratory chain complexes in AML cells, we evaluated the effects of inhibiting mitochondrial protein translation in AML cells and PBSCs. Chemical (tigecycline, and chloramphenicol) and genetic (RNAi knockdown of the EF-Tu) inhibition of mitochondrial translation reduced the levels and function of the respiratory complexes that contain proteins encoded by mitochondrial DNA. Consistent with the reduced reserve capacity, inhibiting mitochondrial translation preferentially reduced oxygen consumption and viability of 1o AML cells and AML cell lines over PBSCs and normal CD34+ cells. To understand the molecular basis for the abnormal mitochondrial biogenesis in 1o AML cells, we measured levels of the NRF-1, TFAM and EF-Tu, genes known to positively regulate mitochondrial biogenesis. Compared to PBSCs, AML samples showed at least a 3-fold increase in mRNA expression of these genes. Myc is a positive regulator of NRF-1, TFAM and EF-Tu. Therefore, we measured levels of myc in 1o AML cells and PBSCs by Q-RT-PCR. Compared to PBSCs, myc was increased in 1o AML cells and positively correlated with expression of NRF-1, TFAM and EF-Tu as well as with mitochondrial mass. To determine whether increased myc expression is functionally related to the increased mitochondrial biogenesis and decreased reserve in respiratory capacity, we employed P493 Burkitt's cells with inducible myc knockdown. P493 cells expressing myc had increased mitochondrial mass, larger mitochondria, and increased basal oxygen consumption compared to the myc knockdown cells. When normalized for mitochondrial mass, myc expressing cells had reduced activity of respiratory complexes III and IV compared to myc knockdown cells. In addition, myc expressing cells had less reserve in respiratory complex III (concentration of antimycin required to reduce oxygen consumption by 50% –+ myc P493 vs –myc P493: 6.580 ± 0.393 nM vs 12.87 ± 1.97 nM p =0.0352). Thus, compared to normal hematopoietic cells, AML cells have greater mitochondrial mass but reduced reserve in their respiratory complexes. As a result of this decreased reserve, AML cells have a heightened sensitivity to inhibition of mitochondrial translation which reduces respiratory chain complex levels and activity. Genetically, the abnormal mitochondrial structure and function appears related to dysregulated myc and its influence on genes promoting increased mitochondrial biogenesis. Disclosures: No relevant conflicts of interest to declare.


2005 ◽  
Vol 16 (11) ◽  
pp. 5202-5214 ◽  
Author(s):  
Katrin Brandner ◽  
David U. Mick ◽  
Ann E. Frazier ◽  
Rebecca D. Taylor ◽  
Chris Meisinger ◽  
...  

The Saccharomyces cerevisiae Taz1 protein is the orthologue of human Tafazzin, a protein that when inactive causes Barth Syndrome (BTHS), a severe inherited X-linked disease. Taz1 is a mitochondrial acyltransferase involved in the remodeling of cardiolipin. We show that Taz1 is an outer mitochondrial membrane protein exposed to the intermembrane space (IMS). Transport of Taz1 into mitochondria depends on the receptor Tom5 of the translocase of the outer membrane (TOM complex) and the small Tim proteins of the IMS, but is independent of the sorting and assembly complex (SAM). TAZ1 deletion in yeast leads to growth defects on nonfermentable carbon sources, indicative of a defect in respiration. Because cardiolipin has been proposed to stabilize supercomplexes of the respiratory chain complexes III and IV, we assess supercomplexes in taz1Δ mitochondria and show that these are destabilized in taz1Δ mitochondria. This leads to a selective release of a complex IV monomer from the III2IV2 supercomplex. In addition, assembly analyses of newly imported subunits into complex IV show that incorporation of the complex IV monomer into supercomplexes is affected in taz1Δ mitochondria. We conclude that inactivation of Taz1 affects both assembly and stability of respiratory chain complexes in the inner membrane of mitochondria.


Sign in / Sign up

Export Citation Format

Share Document